Chemcon Speciality Chemicals Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹65 Cr +21.9% YoYSee revenue, profit and what management said. You are viewing Q2 FY25.
CS

Chemcon Speciality Chemicals Ltd

Q2 FY25Chemicals & Petrochemicals

Chemcon Speciality Chemicals Q2 FY25: Revenue ₹52.6 Cr, EBITDA margin 16.2%

Q2 FY25 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹53Cr
−30% YoY
+15.6% QoQ
Net profit
₹6Cr
+6.6% YoY
+17.9% QoQ
Margin
16.18%
+5.1 pp YoY
+0.5 pp QoQ

Chemcon Speciality Chemicals Ltd Q2 FY25 key numbers

Revenue
Q2 FY25 Revenue from Operations: Rs 52.6 Crs, down from Rs 75.2 Crs in Q2 FY24 (approx. -30% YoY).

As stated in Chemcon Speciality Chemicals Ltd's Q2 FY25 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.

Based on Chemcon Speciality Chemicals Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹228
Market cap₹793 Cr
P/E28.1

The short version

Q2 FY25 Revenue from Operations: Rs 52.6 Crs, down from Rs 75.2 Crs in Q2 FY24 (approx. -30% YoY). Q2 FY25 Financials (Page 6 & 8):

From Chemcon Speciality Chemicals Ltd's Q2 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q2 FY25 Revenue from Operations: Rs 52.6 Crs, down from Rs 75.2 Crs in Q2 FY24 (approx. -30% YoY).
  • Sales Volume (MT) Q2 FY25: 2,877 MT vs. 2,851 MT in Q2 FY24 (slight increase YoY).
  • Revenue Business-wise Q2 FY25: Organic Chemicals 30%, Inorganic Chemicals 68%, Others 2%.
  • Revenue Geographic-wise Q2 FY25: Domestic 43%, Export 57%.
  • Explicit Outlook:
  • Soft performance due to subdued demand in organic chemicals (HMDS, CMIC, Bromobenzene) and volatility in inorganic chemicals.

2 more points from Chemcon Speciality Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Capacity Expansion involves adding two new organic chemical manufacturing units:
  • Proposed P-10 unit expected by Q4 FY25
  • Proposed P-11 unit expected by Q1 FY26
  • Existing installed capacities:
  • Organic Chemicals (HMDS, CMIC, Bromobenzene): 10,800 MTPA
  • Inorganic Chemicals (Bromides): 15,000 MTPA
  • Capital Work in Progress increased from Rs. 13.6 Cr (Mar-23) to Rs. 42.4 Cr (Mar-24), and further to Rs. 48.3 Cr (Sept-24), indicating ongoing investment in expansion projects.

2 more points from Chemcon Speciality Chemicals Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Chemcon Speciality Chemicals Ltd said on order book & pipeline — free account, 30 seconds.

Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Chemcon Speciality Chemicals Ltd Q2 FY25 results — key figures

Chemcon Speciality Chemicals Ltd Q2 FY25 reported results vs Q2 FY24, ₹ crore
₹ CrQ2 FY25Q2 FY24YoYQ1 FY25QoQ
Revenue5375-30%46+15.6%
Operating profit (EBITDA)98+2.2%7+19.5%
Operating margin16.18%11.08%+5.1 pp15.64%+0.5 pp
Profit before tax98+6.1%7+15.9%
Net profit (PAT)66+6.6%5+17.9%
EPS (₹)1.731.62+6.8%1.47+17.7%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹65 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Himadri Special (Q2 FY25)

    1,135.21 Cr, up 13.01% YoY (Page 45) . Key concall takeaways from Himadri Speciality Chemical Ltd's Q2 FY25 earnings call — and how it ranks against sector…

  • Vidhi Specialty (Q2 FY25)

    Year-on-Year (Y-o-Y) growth: 13.9% (Page 8) . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q2 FY25 earnings call — and how it ranks…

  • Valiant Organics (Q2 FY25)

    Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24) . Key concall takeaways from Valiant Organics Ltd's Q2 FY25 earnings call — and how it…

  • Excel Industries (Q2 FY25)

    Q2 FY25 standalone revenue from operations: ₹269 crore, up 1.51% QoQ from Q1 FY25 (₹265 crore). Key concall takeaways from Excel Industries Ltd's Q2 FY25…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Chemcon Speciality Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Chemcon Speciality Chemicals Ltd Q2 FY25 results?

Q2 FY25 Revenue from Operations: Rs 52.6 Crs, down from Rs 75.2 Crs in Q2 FY24 (approx. -30% YoY). Q2 FY25 Financials (Page 6 & 8):

What is Chemcon Speciality Chemicals Ltd share price analysis?

Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.